ACRS
NASDAQ · Pharmaceuticals
Aclaris Therapeutics Inc
$4.50
+0.08 (+1.81%)
Open$4.56
Previous Close$4.42
Day High$4.58
Day Low$4.37
52W High$5.15
52W Low$1.34
Volume—
Avg Volume1.48M
Market Cap628.49M
P/E Ratio—
EPS$-0.56
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+295.3% upside
Current
$4.50
$4.50
Target
$17.79
$17.79
$13.99
$17.79 avg
$22.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.30M | 14.51M | 98.24M |
| Net Income | -77,062,350 | -108,250,530 | 16.97M |
| Profit Margin | -829.6% | -788.1% | 17.3% |
| EBITDA | -90,112,175 | -133,614,119 | 25.23M |
| Free Cash Flow | — | — | 16.84M |
| Rev Growth | -35.9% | -35.9% | +7.1% |
| Debt/Equity | — | — | 1.07 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,124.85 | +0.68% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $245.14 | +1.72% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $124.71 | +3.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.83 | -0.87% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.65 | -0.67% | 12.5 | 33.00B |